FDA

Quadria Capital has partnered with HealthQuad and PwC India to unveil a pivotal report entitled “Financing the Climate-Health Frontier: Emerging Opportunities.” This extensive analysis underscores the vital necessity for increased funding in climate-resilient healthcare infrastructure to mitigate the severe health […]

The NIHR has announced a £25 million funding initiative designed to propel the health and social care system towards achieving net zero. This funding opportunity, representing a multi-programme commitment to climate health and sustainability by the NIHR, seeks to lower

Symbiosis Pharmaceutical Services, a leading CMO specializing in sterile GMP manufacturing of biopharmaceuticals, has announced the expansion of its business development team by welcoming two seasoned US-based directors. Jacqueline Towell will head the efforts on the West Coast, while Cindy

Praxis Precision Medicines, Inc., a biopharmaceutical firm in the clinical development phase, focuses on converting genetic knowledge into treatments for central nervous system (CNS) disorders marked by imbalances in neuron excitation and inhibition. The company has announced plans to present

Hutchmed (China) Limited, a forward-thinking biopharmaceutical firm in the commercial phase, has declared the continuation of Orpathys (savolitinib) in the updated National Reimbursement Drug List (NRDL), following the renewal agreement with China’s National Healthcare Security Administration (NHSA). Scheduled to come

Galderma, a key player in the dermatology field globally, has revealed the complete results of the phase III OLYMPIA 1 trial — a 24-week examination of nemolizumab’s effectiveness and safety in adults with moderate-to-severe prurigo nodularis — in JAMA Dermatology.

Zai Lab Limited, a pioneering biopharmaceutical enterprise engaged in research and commercialization, has disclosed an update pertaining to the inclusion of specific pharmaceuticals and their indications in the 2024 National Reimbursement Drug List (NRDL), as unveiled by the National Healthcare

Kane Biotech Inc. recently announced a new agreement where BioStem Technologies Inc. (BioStem) is set to acquire commercial products and development technologies from ProgenaCare Global LLC (ProgenaCare), Kane Biotech’s existing US distributor. This deal includes exclusive distribution rights in the

Bayer has recently opened its latest life science incubator, Bayer Co.Lab Berlin, strategically positioned on the Global Headquarters Campus of its Pharmaceuticals Division. This facility is proximal to prominent research and clinical institutions. MyoPax GmbH, a Berlin-based enterprise known for

Qiagen, a prominent international leader in Sample to Insight solutions, has unveiled two groundbreaking tools aimed at crafting and acquiring tailored solutions for microbial examination of bacterial, fungal, and viral entities. These innovative resources allow scientists to modify their assays